Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Post translational modification of type IV collagen compensates for basement membrane abnormalities in the kidney glomerulus

FY 2021-22

Summary
Chronic kidney disease is a major global health concern, affecting 850M individuals and resulting in 1M deaths per year. The commonest monogenic disorder that affects the kidneys filtration function is Alport syndrome (AS), leading to multisystem disease affecting sight, hearing and kidney function. AS is caused by variants in COL4A3, COL4A4 or COL4A5, encoding the 5 chains of type IV collagen expressed as rigid heterotrimers in the mature basement membrane of the kidney filter (called glomerulus) to confer mechanical strength opposing capillary blood flow. In AS due to truncating variants, 5 is not formed and there is persistence of flexible heterotrimeric chains of type IV collagen that is normally present in the basement membrane during development. Recently the Barua lab performed mass spectrometry in isolated glomeruli from perinatal Alport (COL4A3 knockout) mice when switching is occuring, demonstrating upregulation of an enzyme responsible for post translational modification of (IV) compared to littermate controls (unpublished). We hypothesize that this upregulation is occurring to stabilize the flexible (IV) and mimic the biomechanical properties of 5 (IV). Our aims are:1. Characterize glomerular enzyme changes over time in AS and wildtype mice with ELISA2. Knockdown enzyme mRNA with administration of siRNA in perinatal AS mice and determine effect 3. Prevent enzyme turnover using a reported inhibitor in perinatal AS mice and determine effect We predict that knockdown will worsen while upregulating enzyme activity will attenuate disease. Ultimately, our work will further mechanistic insight into disease progression and importantly characterize a potential novel molecular target in AS.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467100
Name
De Gregorio Vanessa S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Post translational modification of type IV collagen compensates for basement membrane abnormalities in the kidney glomerulus
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alport Syndrome; Developmental Genetics; Drug Development; Post-Translational Modifications; Protein Dysregulation; Type Iv Collagen
Abstract
Chronic kidney disease is a major global health concern, affecting 850M individuals and resulting in 1M deaths per year. The commonest monogenic disorder that affects the kidneys filtration function is Alport syndrome (AS), leading to multisystem disease affecting sight, hearing and kidney function. AS is caused by variants in COL4A3, COL4A4 or COL4A5, encoding the 5 chains of type IV collagen expressed as rigid heterotrimers in the mature basement membrane of the kidney filter (called glomerulus) to confer mechanical strength opposing capillary blood flow. In AS due to truncating variants, 5 is not formed and there is persistence of flexible heterotrimeric chains of type IV collagen that is normally present in the basement membrane during development. Recently the Barua lab performed mass spectrometry in isolated glomeruli from perinatal Alport (COL4A3 knockout) mice when switching is occuring, demonstrating upregulation of an enzyme responsible for post translational modification of (IV) compared to littermate controls (unpublished). We hypothesize that this upregulation is occurring to stabilize the flexible (IV) and mimic the biomechanical properties of 5 (IV). Our aims are:1. Characterize glomerular enzyme changes over time in AS and wildtype mice with ELISA2. Knockdown enzyme mRNA with administration of siRNA in perinatal AS mice and determine effect 3. Prevent enzyme turnover using a reported inhibitor in perinatal AS mice and determine effect We predict that knockdown will worsen while upregulating enzyme activity will attenuate disease. Ultimately, our work will further mechanistic insight into disease progression and importantly characterize a potential novel molecular target in AS.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
De Gregorio, Vanessa S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~